|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Di Bisceglie AM: Hepatitis B and
hepatocellular carcinoma. Hepatology. 49 (5 Suppl):S56–S60. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deng ZJ, Li L, Teng YX, Zhang YQ, Zhang
YX, Liu HT, Huang JL, Liu ZX, Ma L and Zhong JH: Treatments of
hepatocellular carcinoma with portal vein tumor thrombus: Current
status and controversy. J Clin Transl Hepatol. 10:147–158. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frenette CT, Osorio RC, Stark J, Fok B,
Boktour MR, Guy J, Rhee J and Osorio RW: Conventional TACE and
drug-eluting bead TACE as locoregional therapy before orthotopic
liver transplantation: Comparison of explant pathologic response.
Transplantation. 98:781–787. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miksad RA, Ogasawara S, Xia F, Fellous M
and Piscaglia F: Liver function changes after transarterial
chemoembolization in US hepatocellular carcinoma patients: The
LiverT study. BMC Cancer. 19:7952019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sergio A, Cristofori C, Cardin R, Pivetta
G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A and
Farinati F: Transcatheter arterial chemoembolization (TACE) in
hepatocellular carcinoma (HCC): The role of angiogenesis and
invasiveness. Am J Gastroenterol. 103:914–921. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kudo M, Matsui O, Izumi N, Kadoya M,
Okusaka T, Miyayama S, Yamakado K, Tsuchiya K, Ueshima K, Hiraoka
A, et al: Transarterial chemoembolization failure/refractoriness:
JSH-LCSGJ criteria 2014 update. Oncology. 87 (Suppl 1):S22–S31.
2014. View Article : Google Scholar
|
|
8
|
Sahin TK, Rizzo A, Aksoy S and Guven DC:
Prognostic significance of the royal Marsden hospital (RMH) score
in patients with cancer: A systematic review and Meta-analysis.
Cancers (Basel). 16:18352024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rizzo A, Ricci AD and Brandi G:
Trans-arterial chemoembolization plus systemic treatments for
hepatocellular carcinoma: An update. J Pers Med. 12:17882022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rizzo A, Dadduzio V, Ricci AD, Massari F,
Di Federico A, Gadaleta-Caldarola G and Brandi G: Lenvatinib plus
pembrolizumab: The next frontier for the treatment of
hepatocellular carcinoma? Expert Opin Investig Drugs. 31:371–378.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin J, Huang Y, Zhou H and Yi S: Efficacy
of sorafenib combined with immunotherapy following transarterial
chemoembolization for advanced hepatocellular carcinoma: A
Propensity Score Analysis. Front Oncol. 12:8071022022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang JX, Chen P, Liu S, Zu QQ, Shi HB and
Zhou CG: Safety and efficacy of transarterial chemoembolization and
immune checkpoint inhibition with camrelizumab for treatment of
unresectable hepatocellular carcinoma. J Hepatocell Carcinoma.
9:265–272. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rizzo A, Ricci AD and Brandi G: Systemic
adjuvant treatment in hepatocellular carcinoma: Tempted to do
something rather than nothing. Future Oncol. 16:2587–2589. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Latchman DS: Transcription factors: An
overview. Int J Biochem Cell Biol. 29:1305–1312. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bushweller JH: Targeting transcription
factors in cancer-from undruggable to reality. Nat Rev Cancer.
19:611–624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He Q, Li W, Ren J, Huang Y, Huang Y, Hu Q,
Chen J and Chen W: ZEB2 inhibits HBV transcription and replication
by targeting its core promoter. Oncotarget. 7:16003–16011. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takada H and Kurisaki A: Emerging roles of
nucleolar and ribosomal proteins in cancer, development, and aging.
Cell Mol Life Sci. 72:4015–4025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang G and Zhang G: Upregulation of FoxP4
in HCC promotes migration and invasion through regulation of EMT.
Oncol Lett. 17:3944–3951. 2019.PubMed/NCBI
|
|
19
|
replot (Version sva v3.46.0) [Computer
software], . 2023.Retrieved from. https://github.com/jtleek/sva-devel
|
|
20
|
Lambert SA, Jolma A, Campitelli LF, Das
PK, Yin Y, Albu M, Chen X, Taipale J, Hughes TR and Weirauch MT:
The human transcription factors. Cell. 172:650–665. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hume MA, Barrera LA, Gisselbrecht SS and
Bulyk ML: UniPROBE, update 2015: New tools and content for the
online database of protein-binding microarray data on protein-DNA
interactions. Nucleic Acids Res. 43((Database Issue)): D117–D122.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wingender E, Schoeps T, Haubrock M, Krull
M and Dönitz J: TFClass: Expanding the classification of human
transcription factors to their mammalian orthologs. Nucleic Acids
Res. 46:D343–D347. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
replot (Version 4.0.5) [Computer
software], . 2023.Retrieved from. http://www.R-project.org/
|
|
24
|
replot (Version limma v3.52.0) [Computer
software], . 2023.Retrieved from. https://bioconductor.org/packages/release/bioc/html/limma.html
|
|
25
|
replot (Version pheatmap v1.0.12)
[Computer software], . 2019.Retrieved from. https://cran.r-project.org/web/packages/pheatmap/index.html
|
|
26
|
replot (Version clusterProfiler v4.4.0)
[Computer software], . 2023.Retrieved from. https://bioconductor.org/packages/release/bioc/html/clusterProfiler.html
|
|
27
|
replot (Version WGCNA v1.68) [Computer
software], . 2021.Retrieved from. https://cran.r-project.org/web/packages/WGCNA/index.html
|
|
28
|
replot (Version v1.0.0) [Computer
software], . 2023.Retrieved from. https://cran.r-project.org/web/packages/replot/index.html
|
|
29
|
replot (Version TIMER v2.0) [Computer
software], . 2020.Retrieved from. http://timer.cistrome.org/
|
|
30
|
replot (Version CIBERSORT v1.06) [Computer
software], . 2015.Retrieved from. https://cibersort.stanford.edu/
|
|
31
|
replot (Version quanTIseq v1.0) [Computer
software], . 2019.Retrieved from. https://icbi.i-med.ac.at/software/quantiseq/doc/
|
|
32
|
replot (Version MCP-counter v1.2.0)
[Computer software], . 2021.Retrieved from. https://github.com/ebecht/MCPcounter
|
|
33
|
replot (Version xCell v1.1.0) [Computer
software], . 2017.Retrieved from. https://xcell.ucsf.edu/
|
|
34
|
replot (Version EPIC v1.1) [Computer
software], . 2020.Retrieved from. https://gfellerlab.shinyapps.io/EPIC_1-1/
|
|
35
|
replot (Version ESTIMATE v1.0.13)
[Computer software], . 2013.Retrieved from. https://bioinformatics.mdanderson.org/estimate/
|
|
36
|
Yoshihara K, Shahmoradgoli M, Martinez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thorsson V, Gibbs DL, Brown SD, Wolf D,
Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy
JA, et al: The immune landscape of cancer. Immunity. 48:812–30.e14.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Geeleher P, Cox NJ and Huang RS: Clinical
drug response can be predicted using baseline gene expression
levels and in vitro drug sensitivity in cell lines. Genome Biol.
15:R472014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
replot (Version pRRophetic v1.0.2)
[Computer software], . 2024.Retrieved from. https://github.com/paulgeeleher/pRRophetic2
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Luo Q and Vogeli TA: A Methylation-Based
reclassification of bladder cancer based on immune cell genes.
Cancers (Basel). 12:30542020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shin SW: The current practice of
transarterial chemoembolization for the treatment of hepatocellular
carcinoma. Korean J Radiol. 10:425–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ananthakrishnan A, Gogineni V and Saeian
K: Epidemiology of primary and secondary liver cancers. Semin
Intervent Radiol. 23:47–63. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Islam Z, Ali AM, Naik A, Eldaw M, Decock J
and Kolatkar PR: Transcription Factors: The Fulcrum Between Cell
Development and Carcinogenesis. Front Oncol. 11:6813772021.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Caamano J and Hunter CA: NF-kappaB family
of transcription factors: Central regulators of innate and adaptive
immune functions. Clin Microbiol Rev. 15:414–429. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fachinetti D, Folco HD, Nechemia-Arbely Y,
Valente LP, Nguyen K, Wong AJ, Zhu Q, Holland AJ, Desai A, Jansen
LE and Cleveland DW: A two-step mechanism for epigenetic
specification of centromere identity and function. Nat Cell Biol.
15:1056–1066. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mahlke MA and Nechemia-Arbely Y: Guarding
the Genome: CENP-A-Chromatin in health and cancer. Genes (Basel).
11:8102020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pearson R, Fleetwood J, Eaton S, Crossley
M and Bao S: Kruppel-like transcription factors: A functional
family. Int J Biochem Cell Biol. 40:1996–2001. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Suzuki H, Ohshima N, Tatei K, Taniguchi T,
Sato S and Izumi T: The role of autonomously secreted
PGE2 and its autocrine/paracrine effect on bone matrix
mineralization at the different stages of differentiating MC3T3-E1
cells. Biochem Biophys Res Commun. 524:929–935. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Beilke S, Oswald F, Genze F, Wirth T,
Adler G and Wagner M: The zinc-finger protein KCMF1 is
overexpressed during pancreatic cancer development and
downregulation of KCMF1 inhibits pancreatic cancer development in
mice. Oncogene. 29:4058–4067. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang X, Lu Y, Li C, Larbi A and Feng L,
Shen Q, Chong MS, Lim WS and Feng L: Associations of lifestyle
activities and a heathy diet with frailty in old age: A
Community-based study in Singapore. Aging (Albany NY). 12:288–308.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Preston GC, Feijoo-Carnero C, Schurch N,
Cowling VH and Cantrell DA: The impact of KLF2 modulation on the
transcriptional program and function of CD8 T cells. PLoS One.
8:e775372013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY,
Chang HC, Huang YH and Ling TY: Mesenchymal stem/stromal Cell-based
therapy: Mechanism, systemic safety and biodistribution for
precision clinical applications. J Biomed Sci. 28:282021.
View Article : Google Scholar : PubMed/NCBI
|
